Teodoro Renata Pereira, Scherer Danielle, de Camargo Maria José, da Costa Ana Carolina Carioca, de Andrade Cecília Vianna, Russomano Fábio
Woman's Health Care Area, National Institute of Woman's, Child's and Adolescent's Health, Oswaldo Cruz Foundation, Av. Rui Barbosa, 716, Flamengo, Rio de Janeiro, RJ, CEP 22250-020, Brazil.
Clinical Research Unit, National Institute of Woman's, Child's and Adolescent's Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
BMC Womens Health. 2021 Dec 7;21(1):400. doi: 10.1186/s12905-021-01552-6.
According to the Brazilian Guidelines on Cervical Cancer Screening, women with cytopathologic diagnosis of high-grade intraepithelial lesion, abnormal colposcopic findings, fully visible squamocolumnar junction and age 25 years or older should be treated at the first visit ("see and treat-S&T"). The main limitation to this approach is the risk of overtreatment, identified by histology without preinvasive lesion. The objectives of this study were to identify the overtreatment rate in women undergoing S&T in cervical cancer prevention at a referral center with extensive experience with the method and to detect possible factors associated with this rate.
This was a cross-sectional study that analyzed records from a database with 616 women submitted to S&T from 1996 to 2017. Negative histology was defined as the following histopathologic results: human papillomavirus without cervical intraepithelial neoplasia (CIN), inflammatory, low-grade squamous intraepithelial lesion, and CIN 1.
Of the 616 women, there were 52 (8.44%, 95%CI 6.25-10.64%) with a histopathologic report without preinvasive cervical lesion. No statistical association was found between this outcome and age or a significant downward trend over time.
The overtreatment rate in this study can be considered low and consistent with the acceptable rates reported in the literature, reinforcing the prevailing Brazilian guideline, in which the benefits of immediate treatment outweigh the risk of losses following biopsy.
根据巴西宫颈癌筛查指南,细胞病理学诊断为高级别上皮内病变、阴道镜检查结果异常、鳞柱交界完全可见且年龄在25岁及以上的女性应在首次就诊时接受治疗(“即见即治-S&T”)。这种方法的主要局限性是过度治疗的风险,这可通过无浸润前病变的组织学检查来确定。本研究的目的是在一个对该方法有丰富经验的转诊中心,确定接受S&T的宫颈癌预防女性中的过度治疗率,并检测与此率相关的可能因素。
这是一项横断面研究,分析了一个数据库中的记录,该数据库包含1996年至2017年接受S&T的616名女性。阴性组织学定义为以下组织病理学结果:无宫颈上皮内瘤变(CIN)的人乳头瘤病毒、炎症、低级别鳞状上皮内病变和CIN 1。
在616名女性中,有52名(8.44%,95%CI 6.25-10.64%)的组织病理学报告显示无宫颈浸润前病变。未发现该结果与年龄之间存在统计学关联,也未发现随时间有显著的下降趋势。
本研究中的过度治疗率可被认为较低,与文献报道的可接受率一致,这强化了现行的巴西指南,即立即治疗的益处超过活检后漏诊的风险。